Adam Drapczuk
Director of Finance/CFO at NEXGEL, INC.
Net worth: 150 788 $ as of 31/05/2024
Network origin in Adam Drapczuk first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ.
9
| Private Company | Pharmaceuticals: Major | 9 |
| Public Company | Chemicals: Specialty | 9 | |
West-Ward Pharmaceutical Corp.
 West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Adam Drapczuk via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal | |
| TELIGENT | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Operating Officer | |
| LANNETT COMPANY, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity | |
Anchorage Capital Group LLC
 Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group LLC is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Kevin Ulrich in 2003 as Anchorage Advisors LLC. They are a subsidiary of Anchorage Advisors Management LLC. Anchorage Capital Group provides investment advisory services to private investment funds and structured credit vehicles. | Investment Managers | Director/Board Member | |
| HIKMA PHARMACEUTICALS PLC | Pharmaceuticals: Generic | Sales & Marketing Corporate Officer/Principal | |
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree | |
| Vanderbilt University | College/University | Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity | |
| Clarkson University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Masters Business Admin | |
| Tufts University | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Pharmaceutical Association
 American Pharmaceutical Association Miscellaneous Commercial ServicesCommercial Services The American Pharmaceutical Association represents pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in advancing the profession. The non-profit company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The New Jersey Pharmacists Association | Corporate Officer/Principal | ||
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Nephila Advisors (UK) Ltd.
 Nephila Advisors (UK) Ltd. Financial ConglomeratesFinance Nephila Advisors (UK) Ltd. provides investor relations and business development services to Nephila Capital Ltd. The company was founded on December 12, 2013 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Nephila 2357 Ltd.
 Nephila 2357 Ltd. Specialty InsuranceFinance Nephila 2357 Ltd. is an insurance underwriting and reinsurance services provider. The private company is based in London, UK. The British company was founded in 2012. | Specialty Insurance | Director/Board Member | |
| ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Nautilus Subsidiary, Inc.
 Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Nautilus Biotechnology, Inc. operates as a biopharmaceutical company. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in San Carlos, CA. | Information Technology Services | Director/Board Member | |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
| ROYALTY PHARMA PLC | Pharmaceuticals: Major | Chief Investment Officer | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NAUTILUS BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
| The Andalusia Foundation | Director/Board Member |
Statistics
International
| United States | 39 |
| United Kingdom | 7 |
| Israel | 6 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 6 |
| Health Services | 2 |
Operational
| Director/Board Member | 64 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 24 |
| Director of Finance/CFO | 18 |
| Chairman | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Jerome Zeldis | 38 |
| Dave Stefansky | 21 |
| Melissa Epperly | 13 |
| Miranda Toledano | 13 |
| J. Gregory Jester | 11 |
| Nachum Stein | 11 |
| Jonathan Berlent | 10 |
| Scott Henry | 9 |
| Stephen J. Kovary | 9 |
| Jason Grenfell-Gardner | 9 |
| Damian Finio | 8 |
| Yaakov Spinrad | 7 |
| Antonio di Nicola | 7 |
| Christopher Posner | 6 |
| Steven Glassman | 5 |
- Stock Market
- Insiders
- Adam Drapczuk
- Company connections
